Clinical Trials Directory

Trials / Completed

CompletedNCT01379261

Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction

Rapid Endovascular Catheter Core Cooling Combined With Cold Saline as an Adjunct to Percutaneous Coronary Intervention For the Treatment of Acute Myocardial Infarction

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether treatment of patients suffering from ST-elevation myocardial infarction (STEMI) with 1-2 liters of cold saline and central venous catheter cooling with Philips InnerCool RTx Endovascular System prior to percutaneous coronary intervention (PCI) result in a reduction in infarct size.

Detailed description

Acute myocardial infarction (AMI) is the leading cause of mortality in the western world today. Although reperfusion of the ischemic myocardium is a prerequisite for myocardial salvage, it has been described that the reperfusion in itself may cause additional damage to the myocardium (reperfusion injury). In the safety \& feasibility trial RAPID MI-ICE we demonstrated that treatment of patients suffering from STEMI with 1-2 liters of cold saline and central venous catheter cooling with Philips InnerCool RTx Endovascular System prior to PCI was feasible, safe and resulted in a 38% reduction in infarct size/myocardium at risk. The aim of the present study is to confirm this finding in a larger multicenter trial. The study is a randomized, controlled, evaluator blinded, multicenter trial enrolling 120 patients at ten sites.

Conditions

Interventions

TypeNameDescription
PROCEDURECooling1-2 liters of cold saline and central venous catheter cooling with Philips InnerCool RTx Endovascular System prior to PCI

Timeline

Start date
2011-06-01
Primary completion
2013-09-01
Completion
2013-11-01
First posted
2011-06-23
Last updated
2014-11-06

Locations

10 sites across 4 countries: Austria, Denmark, Slovenia, Sweden

Source: ClinicalTrials.gov record NCT01379261. Inclusion in this directory is not an endorsement.